NASDAQ · Medical Devices · USD
Pulsenmore Ltd. (PLSM) Stock Analysis
Pulsenmore Ltd. (PLSM) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
PLSM Key Statistics
As of Oct 21, 2026Trading
- Open
- $1.79
- Previous Close
- $1.76
- Day's Range
- 1.76–1.85
- 52-Week Range
- 1.71–12.97
- Volume
- 13.23K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.42
Valuation
- Market Cap
- $11.58M
- P/E Ratio
- unprofitable
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −1.33
Financials (FY)
- Revenue (FY)
- $40.02M+314.28%
- Net Income (FY)
- −$15.85M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −65.95%
- Shares Outstanding
- 6.50M
Dividend and dates
- Avg Volume
- 64.39K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
Pulsenmore Ltd. (PLSM) has a market capitalization of $11.58M.
In fiscal 2025, PLSM reported revenue of $40.02M.
PLSM Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $40.02M | −$15.85M | −39.6% |
| 2024 | $9.66M | −$36.74M | −380.3% |
| 2023 | $6.19M | −$58.57M | −946.5% |
| 2022 | $10.81M | −$22.12M | −204.5% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $40.02M | $33.68M | −$12.16M | −$15.85M | −39.6% |
| 2024 | $9.66M | $3.58M | −$42.22M | −$36.74M | −380.3% |
| 2023 | $6.19M | $2.20M | −$55.59M | −$58.57M | −946.5% |
| 2022 | $10.81M | $5.12M | −$46.20M | −$22.12M | −204.5% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
PLSM Valuation vs Medical Devices Median
Median of 145 stocks| Metric | PLSM | Medical Devices median | vs median |
|---|---|---|---|
| Profit margin | −65.95% | −14.78% | 51.2 pts below |
Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer
YahooFull Transcript: Pulsenmore H1 2026 Earnings Call
BenzingaPulsenmore Expands Its Fertility Platform into the UK
YahooPulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring
YahooPulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026
YahooPulsenmore H1 EPS $(1.83), Sales $2.042M
Benzinga
All 8 articles ↓Show fewer ↑
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Devices Stocks
Abbott Laboratories
$173.92B
MDTMedtronic plc.
$119.00B
SYKStryker Corporation
$114.15B
BSXBoston Scientific Corporation
$64.33B
EWEdwards Lifesciences Corporation
$50.95B
GEHCGE HealthCare Technologies Inc.
$31.17B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B






